These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 6125199)

  • 1. The effect of pretreatment with cimetidine on the bioavailability and disposition of atenolol and metoprolol.
    Houtzagers JJ; Streurman O; Regårdh CG
    Br J Clin Pharmacol; 1982 Jul; 14(1):67-72. PubMed ID: 6125199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of metoprolol, propranolol and atenolol with concurrent administration of cimetidine.
    Kirch W; Spahn H; Köhler H; Ohnhaus EE; Mutschler E
    Klin Wochenschr; 1982 Nov; 60(22):1401-7. PubMed ID: 7176462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interaction between H2-receptor antagonists and beta-adrenoceptor blockers.
    Mutschler E; Spahn H; Kirch W
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):51S-57S. PubMed ID: 6146340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation and adverse effects of metoprolol and propranolol after concurrent administration of cimetidine.
    Kirch W; Spahn H; Köhler H; Mutschler E
    Arch Toxicol Suppl; 1983; 6():379-83. PubMed ID: 6578746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of cimetidine on the relative cardioselectivity of atenolol and metoprolol in asthmatic patients.
    Ellis ME; Hussain M; Webb AK; Barker NP; Fitzsimons TJ
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):59S-64S. PubMed ID: 6743475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction of cimetidine with metoprolol, atenolol, propranolol, pindolol and penbutolol.
    Spahn H; Kirch W; Mutschler E
    Br J Clin Pharmacol; 1983 Apr; 15(4):500-1. PubMed ID: 6849789
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of antacid, metoclopramide, and propantheline on the bioavailability of metoprolol and atenolol.
    Regårdh CG; Lundborg P; Persson BA
    Biopharm Drug Dispos; 1981; 2(1):79-87. PubMed ID: 7236872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of inflammatory disease on the clinical pharmacokinetics of atenolol and metoprolol.
    Kirch W; Spahn H; Ohnhaus EE; Köhler H; Heinz U; Mutschler E
    Biopharm Drug Dispos; 1983; 4(1):73-81. PubMed ID: 6839004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacokinetics of atenolol--a review.
    Kirch W; Görg KG
    Eur J Drug Metab Pharmacokinet; 1982; 7(2):81-91. PubMed ID: 6749509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamics of verapamil in combination with atenolol, metoprolol and propranolol.
    Warrington SJ; Holt D; Johnston A; Fitzsimons TJ
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):37S-44S. PubMed ID: 6146339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and pharmacodynamic properties of metoprolol in patients with impaired renal function.
    Jordö L; Attman PO; Aurell M; Johansson L; Johnsson G; Regårdh CG
    Clin Pharmacokinet; 1980; 5(2):169-80. PubMed ID: 6102500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Food-induced reduction in bioavailability of atenolol.
    Melander A; Stenberg P; Liedholm H; Scherstén B; Wåhlin-Boll E
    Eur J Clin Pharmacol; 1979 Nov; 16(5):327-30. PubMed ID: 520399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects on exercise tachycardia during forty-eight hours of a series of doses of atenolol, sotalol, and metoprolol.
    Harron DW; Balnave K; Kinney CD; Wilson R; Russell CJ; Shanks RG
    Clin Pharmacol Ther; 1981 Mar; 29(3):295-302. PubMed ID: 7471600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of a pharmacokinetic interaction between nifedipine and the beta-adrenoceptor blockers metoprolol and atenolol.
    Kendall MJ; Jack DB; Laugher SJ; Lobo J; Rolf Smith S
    Br J Clin Pharmacol; 1984 Sep; 18(3):331-5. PubMed ID: 6487472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the influence of nifedipine on the pharmacokinetics and pharmacodynamics of propranolol, metoprolol and atenolol.
    Gangji D; Juvent M; Niset G; Wathieu M; Degreve M; Bellens R; Poortmans J; Degre S; Fitzsimons TJ; Herchuelz A
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):29S-35S. PubMed ID: 6146337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker.
    Brown HC; Carruthers SG; Johnston GD; Kelly JG; McAinsh J; McDevitt DG; Shanks RG
    Clin Pharmacol Ther; 1976 Nov; 20(5):524-34. PubMed ID: 10125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic aspects of maximal exercise performance after slow release metoprolol and after atenolol.
    Folgering HT; Borm JF; van Haaren RH
    Eur J Clin Pharmacol; 1982 Oct; 23(4):283-8. PubMed ID: 7173299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronopharmacokinetics of beta-receptor blocking drugs of different lipophilicity (propranolol, metoprolol, sotalol, atenolol) in plasma and tissues after single and multiple dosing in the rat.
    Lemmer B; Winkler H; Ohm T; Fink M
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jul; 330(1):42-9. PubMed ID: 2864639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability and disposition of metoprolol and hydrochlorothiazide combined in one tablet and of separate doses of hydrochlorothiazide.
    Jordö L; Johnsson G; Lundborg P; Persson BA; Regärdh CG; Rönn O
    Br J Clin Pharmacol; 1979 Jun; 7(6):563-7. PubMed ID: 465277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between the beta-adrenoceptor blockers metoprolol and atenolol with amitriptyline and their effects on oxidative liver metabolism.
    Kirch W; Spahn H; Kitteringham NR; Hutt HJ; Mutschler E; Ohnhaus EE
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):65S-68S. PubMed ID: 6743476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.